Health-care companies rose as traders rotated into sectors less susceptible to shifts in Federal Reserve policy and inflation trends.
Shares of drug developer CureVac tumbled and the German company's market value nearly halved after disappointing results in a late experimental Covid-19 vaccine, even as executives voiced hope that the shot could still find a use in certain groups.
The Supreme Court rejected a challenge to the Affordable Care Act, the third time it has preserved the 2010 healthcare law.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
06-17-21 1650ET
